UBS Asset Management Americas Inc. maintained its position in ICU Medical Inc. (NASDAQ:ICUI) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 53,303 shares of the company’s stock at the end of the second quarter. UBS Asset Management Americas Inc. owned about 0.33% of ICU Medical worth $6,010,000 as of its most recent SEC filing.
Several other institutional investors have also recently added to or reduced their stakes in ICUI. Bank of Montreal Can purchased a new position in ICU Medical during the second quarter worth approximately $133,000. M&T Bank Corp raised its stake in ICU Medical by 3.3% in the first quarter. M&T Bank Corp now owns 2,117 shares of the company’s stock worth $220,000 after buying an additional 67 shares during the period. Bayesian Capital Management LP raised its stake in ICU Medical by 0.3% in the first quarter. Bayesian Capital Management LP now owns 2,150 shares of the company’s stock worth $224,000 after buying an additional 7 shares during the period. Diversified Trust Co bought a new stake in ICU Medical during the second quarter worth about $237,000. Finally, Janney Montgomery Scott LLC bought a new stake in ICU Medical during the second quarter worth about $240,000. Institutional investors own 89.50% of the company’s stock.
Shares of ICU Medical Inc. (NASDAQ:ICUI) traded down 1.02% during midday trading on Wednesday, reaching $125.69. The company’s stock had a trading volume of 88,933 shares. The stock has a market capitalization of $2.03 billion, a P/E ratio of 37.43 and a beta of 0.49. ICU Medical Inc. has a 12 month low of $85.56 and a 12 month high of $128.93. The stock’s 50-day moving average is $124.65 and its 200 day moving average is $110.71.
ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Monday, August 8th. The company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.10. ICU Medical had a return on equity of 10.33% and a net margin of 14.94%. The business had revenue of $96.70 million for the quarter, compared to the consensus estimate of $89.66 million. During the same quarter in the previous year, the company posted $0.97 earnings per share. ICU Medical’s revenue for the quarter was up 15.4% compared to the same quarter last year. On average, analysts expect that ICU Medical Inc. will post $4.54 earnings per share for the current fiscal year.
ICUI has been the subject of a number of recent research reports. Zacks Investment Research upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $140.00 target price for the company in a research note on Friday, August 12th. Piper Jaffray Cos. reiterated a “neutral” rating and issued a $119.00 target price (up previously from $115.00) on shares of ICU Medical in a research note on Thursday, August 11th.
In other news, Director Joseph R. Saucedo sold 2,000 shares of ICU Medical stock in a transaction on Friday, July 29th. The stock was sold at an average price of $115.47, for a total transaction of $230,940.00. Following the transaction, the director now owns 4,348 shares in the company, valued at $502,063.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Steven Riggs sold 44,739 shares of ICU Medical stock in a transaction on Tuesday, September 13th. The shares were sold at an average price of $121.78, for a total value of $5,448,315.42. Following the transaction, the vice president now owns 675 shares in the company, valued at approximately $82,201.50. The disclosure for this sale can be found here. Insiders own 15.90% of the company’s stock.
About ICU Medical
ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical Inc. (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.